Navigation Links
Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
Date:12/13/2008

oad each year. A world leader in research, drug trialing and diagnostics, The Royal Marsden provides inpatient, day care and outpatient services for all areas of cancer treatment.

About Breakthrough Breast Cancer

Breakthrough Breast Cancer is the UK's leading breast cancer charity committed to fighting breast cancer through research, campaigning and education. In 1999 Breakthrough established the UK's first dedicated breast cancer research centre. The Breakthrough Toby Robins Breast Cancer Research Centre is housed in the Mary-Jean Mitchell Green building at The Institute of Cancer Research and was set up in association with the Royal Marsden Hospital in London. The centre is led by Professor Alan Ashworth FRS. For more information about Breakthrough Breast Cancer, please visit http://www.breakthrough.org.uk.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's belief that conducting studies in additional patient populations and treatment regimens adds value to the Oncotype DX breast cancer assay, the company's belief that clinical evidence and the results of the study reinforce that Oncotype DX is an indispensable tool when making treatment decisions for node-negative and certain node-positive breast cancer patients, and the conclusions from studies needing additional trials or research and the ability of the company to conduct such studies or research . These risks and uncertainties include, but are not limited to: the results of additional clinical studies; the applicability of clinical study results to actual outcomes; the risk that the company may not obtain sufficient levels of reimbursement for any future tests it may develop; the company's ability to develop and commercia
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... New location, same quality of ... it is accepting new patients at its newly ... , The new location opened its doors Feb. ... programs, including the following programs: , Comprehensive physical ... -Vestibular rehabilitation, -Neurological rehabilitation, -Balance and fall prevention, ...
(Date:2/26/2015)... 2015 Miami auto accident lawyer, Sean M. ... a new, useful addition by making it possible for drivers ... , “Given the fact that last year (2014) was a ... keeping drivers - especially those car accident victims who were ... recall issues is important.” – Personal injury lawyer, Sean M. ...
(Date:2/26/2015)... The report segments the European patient handling equipment ... accessory, and region. The medical beds segment accounted ... handling equipment market, by product. However, the nonmechanical ... highest CAGR in the forecast period. , ... On the basis of type of care, the ...
(Date:2/26/2015)... Imagine a day without access to clean, drinkable water and ... no one to help. For more than 783 million people ... than 2.5 billion people will also lack access to basic ... led by Nevada’s Desert Research Institute (DRI) is ... – who often bear the brunt of the impact from ...
(Date:2/26/2015)... Ore. (PRWEB) February 26, 2015 ... services, celebrated its launch to its first customer ... employees and their covered dependents. , SpendWell ... health care services, combining real-time price transparency with ... a variety of routine health care services and ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy Accepting New Patients at Relocated Battlefield Clinic 2Health News:Auto Recalls Additional Feature, Sean M. Cleary Miami Auto Accident Lawyer 2Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 2Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 3Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3
... of Medicine may have found a way to turn an ... normal cells are starved for food, they chew up existing ... that process, called autophagy, using it to survive when they ... from chemotherapy and other sources. When the Penn investigators ...
... more than 100,000 patients in the U.S. undergo implantation ... rhythm abnormalities. This number constitutes a 20-fold increase over ... of end of life care of these medical devices, ... options. Now, researchers at the University of Pennsylvania School ...
... April 5 (HealthDay News) -- The inner ear can actually "store" ... in the inner ear continue even after a sound has ended ... The study is published in the April 5 issue of the ... investigators found that after-vibrations in the inner ear were dependent on ...
... April 5, 2011 Despite a growing number of cities ... up everywhere from chic downtown cafes to locations near ... young adults. A new study done by researchers at ... popular pastime, and the results are discouraging. "The ...
... Cardiac & Vascular Institute at NYU Langone Medical Center ... Cardiology 60th Annual Scientific Session held April 2-5, 2011 ... NYU Langone cardiologists included: The Relationship between ... vs. Aspirin Alone: Results from the CHARISMA Trial , ...
... By Ellin Holohan HealthDay Reporter , MONDAY, April ... long workday to the list of risk factors for heart disease. ... in England significantly increased their chances of having a heart attack ... by researchers at University College London, found that employees who regularly ...
Cached Medicine News:Health News:Modern targeted drug plus old malaria pill serve a 1-2 punch in advanced cancer patients 2Health News:Penn study sheds light on end of life management of implanted defibrillators 2Health News:Hookah use widespread among college students 2Health News:Hookah use widespread among college students 3Health News:NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session 2Health News:NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session 3Health News:NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session 4Health News:Too Many Hours at Work Might Harm the Heart 2Health News:Too Many Hours at Work Might Harm the Heart 3
(Date:2/26/2015)... -- Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or ... a noninvasive  device that tracks blood glucose levels, announced today ... its new scientific advisory board that is expected to ... research, monitoring and treatment. Prof. Dr. ... and Head, Business Development of Profil Institute for Metabolic ...
(Date:2/26/2015)... , Feb. 26, 2015 People ... have the opportunity to participate in research that ... the first independent U.S. psoriasis registry begins recruiting ... joint collaboration with the National Psoriasis Foundation and ... reporting for secukinumab, a new biologic medication by ...
(Date:2/26/2015)... , Feb. 26, 2015 Surna Inc. ... specializing in commercial indoor cannabis cultivation technology, announced ... from start-up to fast-paced manufacturing and engineering company. ... , current Director and CEO, will be stepping ... proud of what the team has accomplished thus ...
Breaking Medicine Technology:Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4
... 1, 2011 PTC Therapeutics, Inc. (PTC) today announced ... of ataluren, an investigational new drug, in adults with ... Respiratory Journal . The published three-month data showed that ... chloride channel activity, CF-related cough and positive trends in ...
... READING, England and BEDMINSTER, N.J., June 30, 2011 ... Inc., today announced that the U.S. Food and Drug ... the management of breakthrough pain in cancer patients 18 ... and who are tolerant to opioid therapy for their ...
Cached Medicine Technology:Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 2Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 3Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 4Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 5Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 2FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 3FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 4FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 5FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 8
... Shoulder Holder is used for positioning the ... position. The shoulder holder is adjustable with ... arm positions and sizes. The MITT allows ... arm in the shoulder holder during surgery. ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Made exclusively from LactoSorb® Resorbable Copolymer....
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
Medicine Products: